Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma

被引：43

作者：

Mehta, Anurag ^{[1
]}

Gupta, Arjun ^{[1
]}

Hannallah, Franck ^{[1
]}

Koshy, Thomas ^{[2
]}

Reimold, Sharon ^{[2
]}

机构：

[1] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA

[2] Univ Texas SW Med Ctr Dallas, Dept Cardiol, Dallas, TX 75390 USA

来源：

关键词：

D O I：

10.1097/CMR.0000000000000251

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：319 / 320

页数：2

共 5 条

[1] Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome
Geisler, Benjamin P.
Raad, Roy A.
Esaian, Diana
Sharon, Elad
Schwartz, David R.
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
[2] Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
Laeubli, Heinz
Balmelli, Cathrin
Bossard, Matthias
Pfister, Otmar
Glatz, Kathrin
Zippelius, Alfred
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
[3] Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]
[4] U.S. Food and Drug Administration, 2015, NIV COMB IP
[5] U.S. National Cancer Institute, 2009, NCI COMM TERM CRIT A